Abstract:Objective To examine the genetic associations of metabolic syndrome (MetS) with frailty and mental disorders [depression, schizophrenia (SCZ), and bipolar disorder (BIP)], along with causality between frailty and MetS and the mediating role of mental disorders. Methods The summary-level datasets were obtained from recent genome-wide association studies. The genetic correlation was explored from the perspectives of global and local genetic correlation. Univariate Mendelian Randomization (UMR) was used to investigate the causal link between frailty and metabolic syndrome (MetS), followed by multivariate MR to address the confounding effects of body mass index (BMI) and physical activity (PA). Finally, two-step MR analyses were conducted to examine whether the causal relationship was mediated by mental disorders. Results The global genetic correlation analyses presented MetS was positively associated with frailty and depression, but reversely related to SCZ. Similarly, MetS was locally correlated to frailty, depression, and SCZ in numerous genomic regions. The UMR demonstrated that fragile people have a higher likelihood of suffering from MetS (OR: 2.773, 95% CI: 1.455-5.286, p = 0.002), and reversely people with MetS tended to be more fragile (beta: 0.211, 95% CI: 0.180-0.241, p < 0.001). This bidirectional causal association still existed even after adjusting for BMI and PA. The mediation analyses implied this causality was mediated by depression, but not SCZ and BIP. Conclusion Our research provided evidence of genetic correlations between MetS and frailty, depression, and SCZ. Additionally, we discovered a bidirectional causality between frailty and MetS, with depression playing a significant mediating role. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This study did not receive any funding ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The data sets used in this research were publicly available from the published articles, and the ethics approvals were obtained in the original research. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes The datasets utilized in this study are accessible on the IEU OpenGWAS project (), figshare (), PGC (), and iPSYCH ().

Exploring the shared genetic basis of major depressive disorder and frailty

Dissecting the shared genetic architecture between Alzheimer's disease and frailty: a cross-trait meta-analyses of genome-wide association studies

Association between frailty and depression: A bidirectional Mendelian randomization study

A Joint Study of Whole Exome Sequencing and Structural MRI Analysis in Major Depressive Disorder.

Shared Genetic Architecture Highlights the Bidirectional Association Between Major Depressive Disorder and Fracture Risk

Investigating the shared genetic architecture between frailty and insomnia

Gut Microbiome and Frailty: Insight from Genetic Correlation and Mendelian Randomization

Overlapping Common Genetic Architecture Between Major Depressive Disorders and Anxiety and Stress-Related Disorders.

Dissecting shared genetic architecture between depression and body mass index

A Systematic Analysis on the Genes and Their Interaction Underlying the Comorbidity of Alzheimer's Disease and Major Depressive Disorder

Genetic modification effects of physical frailty on the morbidity of mental disorders in the UK Biobank

Frailty, Mental Disorders, and Metabolic Syndrome: A Genetic Association and Mediation Mendelian Randomization Study

Uncovering the multivariate genetic architecture of frailty with genomic structural equation modelling

Molecular and Genetic Characterization of Depression: Overlap with Other Psychiatric Disorders and Aging

Shared genetic architecture of cortical thickness alterations in major depressive disorder and schizophrenia

A cross-tissue transcriptome-wide association study identifies new susceptibility genes for frailty

Frailty increases depression risk independently of cognitive decline: Insights from Mendelian randomization and cross-sectional analysis

Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets

Causes and consequences of major depressive disorder: An encompassing Mendelian randomization study

Investigating the shared genetic architecture between depression and subcortical volumes

Physical frailty and the risk of major depressive disorder: The Irish Longitudinal Study on Ageing.